Publication Overview
This update includes 13 PubMed publications with abstracts from the monitoring period 2026-06-07 to 2026-06-15. The most common focus areas are comorbiditiesComorbidity: An additional condition existing alongside the primary disease. Acne Inversa is frequently associated with comorbidities including metabolic syndrome, inflammatory bowel disease, spondyloarthritis, and depression., quality of life, surgery, pain, biologicsBiologic: A class of medications derived from living cells that target specific components of the inflammatory process. For Acne Inversa, biologics such as adalimumab and secukinumab are used when other treatments are insufficient..
- Comparison to the previous update: not automatically assessed.
- This selection is a research overview, not a guideline and not medical advice.
Top Highlights
The most important signals in this round are not found in a single treatment recommendation, but in the questions researchers are currently examining more closely: wound healing after procedures, new anti-inflammatory approaches, quality of care, and comorbidities.
- Rapid RemissionRemission: A phase in which disease activity significantly decreases or is temporarily not noticeable. Complete cure in Acne Inversa is rare; however, remissions are possible and an important treatment goal. through Multimodal Therapy in a Severe Form of PASH Syndrome: A Case Report.: The abstract describes a new publication. In terms of content, it mainly addresses: PASH syndrome is a rare autoinflammatory dermatosis characterized by the triad of pyoderma gangrenosumPyoderma Gangrenosum: A rare, painful, ulcerative skin condition that sometimes occurs alongside Acne Inversa. (PG), acne conglobataAcne Conglobata: A severe, scarring form of nodulocystic acne, usually on the back, chest, and buttocks. Shares mechanistic and immunological overlap with Acne Inversa., and hidradenitis suppurativa (HS), driven by innate immune dysregulation and IL-1-mediated… What is new or notable here is that the topic of HS is approached from the perspective of biologics, surgery, wound care, pain. The most important limitation: based on the abstract alone, study design, patient selection, and follow-up period can only be assessed to a limited extent. (PMID 42256375)
- Palliative and Supportive Care Needs in Advanced Hidradenitis Suppurativa: A Systematic Review.: The abstract describes a systematic review. In terms of content, it mainly addresses: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition associated with severe symptom burden, high psychiatric comorbidity, and profound impairment in health-related quality of life (HRQoL). Despite th… What is new or notable here is that the topic of HS is approached from the perspective of comorbidities, quality of life, pain. The most important limitation: the informative value depends on how good and how comparable the included studies are; abstracts also do not reveal every methodological weakness. (PMID 42272576)
- Informatics-Based Psychotherapeutic and Psychiatric Interventions in DermatologyDermatology: The medical specialty concerned with diagnosing and treating skin conditions. Acne Inversa is often managed by dermatologists, although surgery and other specialties may also be involved.: Scoping Review of Impacts on Skin Disease Severity and Mental Health Outcomes.: The abstract describes a new publication. In terms of content, it mainly addresses: Chronic dermatologic conditions such as psoriasis, atopic dermatitis, and hidradenitis suppurativa are associated with a high burden of psychiatric comorbidities, including depression, anxiety, and suicidality. Despit… What is new or notable here is that the topic of HS is approached from the perspective of comorbidities, quality of life. The most important limitation: based on the abstract alone, study design, patient selection, and follow-up period can only be assessed to a limited extent. (PMID 42269173)
- Meta-inflammation in Hidradenitis suppurativa: from pathogenic evidence to therapeutic approaches.: The abstract describes a new publication. In terms of content, it mainly addresses: Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disorder of the pilosebaceous unitPilosebaceous Unit: The combined structure of a hair, its follicle, and the attached sebaceous (oil) gland. Acne Inversa is now classified as a disease of the pilosebaceous unit, not of sweat glands as was long incorrectly assumed., characterized by nodulesNodule: A firm, palpable lump deep in tissue. Nodules can be painful and may progress to abscesses. They are among the typical early signs of Acne Inversa., abscessesAbscess: An inflamed cavity or swelling containing pus or fluid. In hidradenitis suppurativa, abscesses can form as part of the inflammatory disease process and do not automatically mean that a bacterial infection is present. Secondary bacterial infection can occur and may require separate medical assessment. In Acne Inversa, abscesses occur mainly in the armpits, groin, and other skin folds., and sinus tractsSinus Tract: A tunnel-like channel under the skin that forms between abscesses or nodules. Sinus tracts indicate more advanced disease and can chronically drain fluid. They are associated with Hurley Stages II and III. formation in apocrine glandApocrine Gland: A type of sweat gland concentrated in the armpits, groin, around the nipples, and the anus. Long considered the origin of Acne Inversa — hence the name 'hidradenitis' — apocrine glands sit near the follicles HS affects but are bystanders, not the trigger.-bearing skin. Increasing ev… What is new or notable here is that the topic of HS is approached from the perspective of biologics, comorbidities. The most important limitation: based on the abstract alone, study design, patient selection, and follow-up period can only be assessed to a limited extent. (PMID 42266681)
- The Impact of Hidradenitis Suppurativa on Sexual Function: A Multicentered Cross-Sectional Study.: The abstract describes a multicenter study. In terms of content, it mainly addresses: Hidradenitis suppurativa (HS) is a disease that impairs the quality of life (QoL), sexual functioning, and fertility of the patients. The relationship between disease characteristics and sexual function remains insuff… What is new or notable here is that the topic of HS is approached from the perspective of quality of life, pain. The most important limitation: based on the abstract alone, study design, patient selection, and follow-up period can only be assessed to a limited extent. (PMID 42268671)
Featured Publication
The featured paper is IL-1-Targeted Therapy in Dermatologic Conditions. from Journal of the American Academy of Dermatology (PMID 42264383). The abstract mainly addresses: Interleukin-1 (IL-1) plays a key role in inflammasome activation, keratinocyte signalling and neutrophil recruitment, and is a driving force behind many neutrophil-rich and suppurative dermatoses. There is robust evid…
Why it stands out: The publication fits the focus topics no automatic topic tagging and shows which questions are currently being examined more closely in HS. It is particularly relevant for readers because it provides a concrete example of how research contextualizes an everyday topic or a possible mechanism. The most important limitation remains: based on the abstract alone, study design, patient selection, and follow-up period can only be assessed to a limited extent.
What This Could Mean for You (patient-friendly, without recommendations)
If you live with HS, research updates can help you make sense of terms and trends — for example, which measures (pain, quality of life) are used in studies, or which comorbidities are increasingly being considered alongside HS.
It’s important to note: even when individual studies sound exciting, they usually don’t yet say anything about what is right for you personally. Use new findings as a conversation starter (e.g., “What goals are realistic for me?” or “Which comorbidities should I keep an eye on?”) — not as an instruction for action.
What We Don’t Know / Limitations
- This update only considers PubMed entries with an abstract (without an abstract, a reliable summary is barely possible).
- Studies differ considerably (design, population, measurement methods).
- This update provides no treatment recommendations and does not assess individual risks.
Important: Decisions Belong in the Conversation with Your Doctor
This article is an editorial overview and has not been medically reviewed. If anything in this overview unsettles or interests you, use it as a conversation starter for your next appointment. Medications, surgeries, and diagnostics should always be discussed together with qualified medical professionals.
FAQ
Why does this only cover a few new publications?
This format filters strictly: only new PubMed entries within the monitoring window that have an abstract and have not already been covered in previous posts are included.
Does a new study mean my treatment should change?
No. Individual publications may be interesting, but they usually aren’t sufficient to draw conclusions for decisions for a specific person.
Why are limitations and uncertainties emphasized so strongly?
Because abstracts only show part of the overall picture. Study design, patient group, endpoints, and follow-up period all need to be considered before interpreting results.
Sources & Original Studies
For each point, you will find the original source below (PubMed link, and DOI/PMCID where available).
Terms explained in this article
Quick definitions of the key medical terms. Select any term for its full glossary entry.
- Comorbidity
- An additional condition existing alongside the primary disease. Acne Inversa is frequently associated with comorbidities including metabolic syndrome, inflammatory bowel disease, spondyloarthritis, and depression.
- Biologic
- A class of medications derived from living cells that target specific components of the inflammatory process. For Acne Inversa, biologics such as adalimumab and secukinumab are used when other treatments are insufficient.
- Remission
- A phase in which disease activity significantly decreases or is temporarily not noticeable. Complete cure in Acne Inversa is rare; however, remissions are possible and an important treatment goal.
- Pyoderma Gangrenosum
- A rare, painful, ulcerative skin condition that sometimes occurs alongside Acne Inversa.
- Acne Conglobata
- A severe, scarring form of nodulocystic acne, usually on the back, chest, and buttocks. Shares mechanistic and immunological overlap with Acne Inversa.
- Dermatology
- The medical specialty concerned with diagnosing and treating skin conditions. Acne Inversa is often managed by dermatologists, although surgery and other specialties may also be involved.
- Pilosebaceous Unit
- The combined structure of a hair, its follicle, and the attached sebaceous (oil) gland. Acne Inversa is now classified as a disease of the pilosebaceous unit, not of sweat glands as was long incorrectly assumed.
- Nodule
- A firm, palpable lump deep in tissue. Nodules can be painful and may progress to abscesses. They are among the typical early signs of Acne Inversa.
- Abscess
- An inflamed cavity or swelling containing pus or fluid. In hidradenitis suppurativa, abscesses can form as part of the inflammatory disease process and do not automatically mean that a bacterial infection is present. Secondary bacterial infection can occur and may require separate medical assessment. In Acne Inversa, abscesses occur mainly in the armpits, groin, and other skin folds.
- Sinus Tract
- A tunnel-like channel under the skin that forms between abscesses or nodules. Sinus tracts indicate more advanced disease and can chronically drain fluid. They are associated with Hurley Stages II and III.
- Apocrine Gland
- A type of sweat gland concentrated in the armpits, groin, around the nipples, and the anus. Long considered the origin of Acne Inversa — hence the name 'hidradenitis' — apocrine glands sit near the follicles HS affects but are bystanders, not the trigger.
References
- New Frontiers of Skin Ultrasound in Precision Medicine. Ultrasound in medicine & biology, 2026 — PMID 42285862 · DOI 10.1016/j.ultrasmedbio.2026.05.015
- Informatics-Based Psychotherapeutic and Psychiatric Interventions in Dermatology: Scoping Review of Impacts on Skin Disease Severity and Mental Health Outcomes. JMIR dermatology, 2026 — PMID 42269173 · DOI 10.2196/82096 · PMCID PMC13252885
- Enhanced Diagnosis of Generalized Pustular Psoriasis With the Legit.Health Device as a Diagnosis Support Tool: Multireader Multicase Study. JMIR dermatology, 2026 — PMID 42269023 · DOI 10.2196/82030 · PMCID PMC13252704
- The Impact of Hidradenitis Suppurativa on Sexual Function: A Multicentered Cross-Sectional Study. International journal of dermatology, 2026 — PMID 42268671 · DOI 10.1111/ijd.70522
- IL-1-Targeted Therapy in Dermatologic Conditions. Journal of the American Academy of Dermatology, 2026 — PMID 42264383 · DOI 10.1016/j.jaad.2026.06.021
- Comparing the measurement properties, informativity and responsiveness of the DLQI, DLQI-Relevant (DLQI-R), and Skindex-29 in patients with chronic skin disease: a prospective cohort study. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2026 — PMID 42260199 · DOI 10.1007/s11136-026-04286-w
- Thoracodorsal Artery Perforator Flap Versus Split-Thickness Skin Graft Reconstruction for Advanced Axillary Hidradenitis Suppurativa: Long-Term Outcomes. Journal of clinical medicine, 2026 — PMID 42279256 · DOI 10.3390/jcm15114395
- Redundant γc cytokines license IL-1-driven neutrophil inflammation through MEK/ERK convergence. bioRxiv : the preprint server for biology, 2026 — PMID 42282585 · DOI 10.64898/2026.05.28.728506 · PMCID PMC13252156
- Meta-inflammation in Hidradenitis suppurativa: from pathogenic evidence to therapeutic approaches. Frontiers in immunology, 2026 — PMID 42266681 · DOI 10.3389/fimmu.2026.1827227 · PMCID PMC13243088
- Palliative and Supportive Care Needs in Advanced Hidradenitis Suppurativa: A Systematic Review. Cureus, 2026 — PMID 42272576 · DOI 10.7759/cureus.108573 · PMCID PMC13247365
- Staphylococcal proliferation on skin models to investigate novel anti-infective treatments against dysbiosis. Bioengineering & translational medicine, 2026 — PMID 42272967 · DOI 10.1002/btm2.70124 · PMCID PMC13247412
- [Climate change and skin]. Revue medicale de Liege, 2026 — PMID 42257359
- Rapid Remission through Multimodal Therapy in a Severe Form of PASH Syndrome: A Case Report. Case reports in dermatology, 2026 — PMID 42256375 · DOI 10.1159/000551256 · PMCID PMC13241081